Evidence map›Paper›PMID 32728045›Full record

SynthesisScientific reports2020

PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis.

Negar Sarhangi, Farshad Sharifi, Leila Hashemian, Maryam Hassani Doabsari, Katayoun Heshmatzad, Marzieh Rahbaran, Seyed Hamid Jamaldini, Hamid Reza Aghaei Meybodi, Mandana Hasanzad

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Biomedical reports · 2025
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Genetic Associations ofDiagnostics (Basel, Switzerland) · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Negar SarhangiPersonalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, 1411413137, Tehran, Iran.
Farshad SharifiElderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, 1411413137, Tehran, Iran.
Leila HashemianMedical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, 1916893813, Tehran, Iran.
Maryam Hassani DoabsariMedical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, 1916893813, Tehran, Iran.
Katayoun HeshmatzadMedical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, 1916893813, Tehran, Iran.
Marzieh RahbaranMedical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, 1916893813, Tehran, Iran.
Seyed Hamid JamaldiniMedical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, 1916893813, Tehran, Iran.
Hamid Reza Aghaei MeybodiPersonalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, 1411413137, Tehran, Iran.
Mandana HasanzadPersonalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, 1411413137, Tehran, Iran. mandanahasanzad@yahoo.com.
Islamic Azad University Medical Branch of Tehran · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2DM) is a complex disease caused by the interaction between genetic and environmental factors. A growing number of evidence suggests that the peroxisome proliferator-activated receptor gamma (PPARG) gene plays a major role in T2DM development. Meta-analysis of genetic association studies is an efficient tool to gain a better understanding of multifactorial diseases and potentially to provide valuable insights into gene-disease interactions. The present study was focused on assessing the association between Pro12Ala variation in the PPARG and T2DM risk through a comprehensive meta-analysis. We searched PubMed, WoS, Embase, Scopus and ProQuest from 1990 to 2017. The fixed-effect or random-effect model was used to evaluate the pooled odds ratios (ORs) and 95% confidence intervals (CIs) depending on the heterogeneity among studies. The sources of heterogeneity and publication bias among the included studies were assessed using I

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAllelesDiabetes Mellitus, Type 2Disease ProgressionGene FrequencyGenetic Association StudiesGenotypeHumansOdds RatioPPAR gammaPrecision MedicineRiskPPAR gammaPPARG protein, human

Identifiers

PMID32728045
PMCPMC7391673
OpenAlexW3045716234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.